title: Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity.
abstract: The seeds of Rhynchosia volubilis (SRV) (Leguminosae) and soybean have been used in oriental folk medicine to prevent postmenopausal osteoporosis. Their beneficial effects are caused by a high content of isoflavone, which function as partial agonists or antagonists of estrogen. To compare the estrogenic effects of SRV and soybean on the MG-63 osteoblastic cell proliferation, 70% methanol extracts of SRV or soybean were treated on MG-63 cells. Although biphasic over a concentration range of 0.001 mg/ml-0.1 mg/ml, both SRV and soybean extracts increased MG-63 cell proliferation. However SRV was more effective at increasing the cell proliferation that paralleled with the greater estrogenic effects as determined by estrogen receptor alpha (ERalpha) expression, an estrogenic response element (ERE)-luciferase activity and the selective expression of insulin-like growth factor-I (IGF-I). SRV-induced IGF-I expression resulted from increases in the mRNA levels. Despite the increased expression of ERbeta, ERE activity and IGF-I expression by soybean were lower than those by SRV. Furthermore, the comparable estrogenic effects between SRV and the combined treatment of genistein and daidzein standards at 0.5 x 10(-8) M, which is a concentration of these two isoflavones similar to that of SRV at 0.001 mg/ml, demonstrate that the greater estrogenicity of SRV for MG-63 cell proliferation is mediated by the synergism of low levels of isoflavones for the selective expression of IGF-I.
authors.affiliation: Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Hoeki-dong 1, Dongdaemoon-gu, Seoul 130-701, Republic of Korea.
authors.forename: J
authors.initials: J
authors.lastname: Kim
authors.forename: S J
authors.initials: SJ
authors.lastname: Um
authors.forename: J
authors.initials: J
authors.lastname: Woo
authors.forename: J Y
authors.initials: JY
authors.lastname: Kim
authors.forename: H A
authors.initials: HA
authors.lastname: Kim
authors.forename: K H
authors.initials: KH
authors.lastname: Jang
authors.forename: S A
authors.initials: SA
authors.lastname: Kang
authors.forename: B O
authors.initials: BO
authors.lastname: Lim
authors.forename: I
authors.initials: I
authors.lastname: Kang
authors.forename: R W
authors.initials: RW
authors.lastname: Choue
authors.forename: Y
authors.initials: Y
authors.lastname: Cho
mesh_terms: D015152:Blotting, Northern; D015153:Blotting, Western; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000096:biosynthesis; D047629:Estrogen Receptor beta / Q000096:biosynthesis; D004967:Estrogens / Q000096:biosynthesis*; D007887:Fabaceae / Q000737:chemistry*; D000077267:Fulvestrant; D017930:Genes, Reporter / Q000235:genetics; D006133:Growth Substances / Q000096:biosynthesis; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis; D008156:Luciferases / Q000235:genetics; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism*; D010936:Plant Extracts / Q000494:pharmacology; D010957:Plasmids / Q000235:genetics; D011960:Receptors, Estrogen / Q000096:biosynthesis; D020218:Response Elements / Q000187:drug effects; D012639:Seeds / Q000737:chemistry; D013025:Glycine max / Q000737:chemistry*; D015533:Transcriptional Activation / Q000187:drug effects
chemical_list: D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; D006133:Growth Substances; D010936:Plant Extracts; D011960:Receptors, Estrogen; D000077267:Fulvestrant; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D008156:Luciferases